RE: Testing16 Jan 2024 14:25
Strong performance in operations with FoodPrint® yields significantly improved.
SIGNIFICANT IMPROVEMENT? REALLY? SO WHY ARE THEY STILL MAKING A LOSS?
· First USA laboratory commercialising FoodPrint®.
AND WHAT ARE THE SALES?
· MyHealth Tracker roll out expanding to all UK customers and installed in one European country.
AND ? SALES?
· Microbiome menu expansion moving into trial phase in UK.
SO NOT BEING SOLD?
· Creation of a continuous improvement function to build on the work done by Chartwell Consulting.
YEAH? SALES?
· Appointment of new independent Non-Executive Director, Carolyn Rand.
AND? WHAT DIFFERENCE WILL IT MAKE APART FROM MORE WAGES?
Successful name change to Cambridge Nutritional Sciences Plc (AIM: CNSL), better reflecting the standalone business.
WELL DONE!..THEY MANAGED TO CHANGE THE NAME....LOL ..ONLY ODX / CNSL COULD THINK THAT WAS A BIG ACHIEVEMENT
30 YEARS OF BUILDING THE BRAND DISCARDED....